At the time of writing, DBV Technologies ADR [DBVT] stock is trading at $6.20, up 58.57%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DBVT shares have gain 24.25% over the last week, with a monthly amount glided 47.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DBV Technologies ADR [NASDAQ: DBVT] stock has seen the most recent analyst activity on January 04, 2023, when Societe Generale upgraded its rating to a Buy. Previously, Goldman downgraded its rating to Sell on December 16, 2022. On May 10, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $1.50 on the stock. Societe Generale upgraded its rating to a Buy. Societe Generale downgraded its rating to a Sell. Societe Generale upgraded its rating to Hold for this stock on November 02, 2020. In a note dated August 06, 2020, Societe Generale downgraded an Sell rating on this stock.
For the past year, the stock price of DBV Technologies ADR fluctuated between $2.20 and $8.32. DBV Technologies ADR [NASDAQ: DBVT] shares were valued at $6.20 at the most recent close of the market.
Analyzing the DBVT fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -9.15%, Pretax Profit Margin comes in at -8.92%, and Net Profit Margin reading is -8.92%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -1.04 and Total Capital is -1.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.41 points at the first support level, and at 4.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.89, and for the 2nd resistance point, it is at 7.57.
Ratios To Look Out For
It is important to note that DBV Technologies ADR [NASDAQ:DBVT] has a current ratio of 2.22. Further, the Quick Ratio stands at 2.22, while the Cash Ratio is 1.5.
Transactions by insiders
Recent insider trading involved Mohideen Pharis, Chief Medical Officer, that happened on Jan 30 ’25 when 600.0 shares were sold. Chief Medical Officer, Mohideen Pharis completed a deal on Nov 25 ’24 to sell 565.0 shares. Meanwhile, Chief Medical Officer Mohideen Pharis sold 342.0 shares on Nov 22 ’24.
